Key facts
- It has raised $14.5M; the latest was Early Stage VC ($14.5M) in Mar 2026.
- Notable investors include Shenzhen Capital Group, Co-Stone Capital, SDIC Unity Capital, Teda VC, Green River Investment — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Betterway Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Betterway Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Betterway Medtech
Developer of medical equipment designed for peripheral vessels and structural heart diseases. The company offers non-implantable medical devices, thereby enabling patients with effective medical devices for peripheral vessels and structural heart diseases.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Website
- betterwaymed.com/
- Ownership
- Privately Held (backing)
Betterway Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Betterway Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Betterway Medtech in its N-PORT filings yet. We sweep new filings monthly.